LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)

CNY 8.12

(0.25%)

Market Cap (In CNY)

4.14 Billion

Revenue (In CNY)

1.16 Billion

Net Income (In CNY)

67.18 Million

Avg. Volume

5.1 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.84-10.15
PE
-
EPS
-
Beta Value
0.22
ISIN
CNE1000019W4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yingchun Wang
Employee Count
-
Website
https://www.fczy.com
Ipo Date
2011-12-22
Details
LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It offers its products in various dosage forms, including pills, tablets, capsules, and granules under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products to approximately 27 countries, which include the United States, Canada, Japan, Australia, Russia, Ukraine, Singapore, Indonesia, Thailand, Malaysia, New Zealand, Hong Kong, etc. The company was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci Pharmaceutical Factory.